Calcification of left-sided valvular structures: Evidence of a pro-inflammatory milieu

Journal of Heart Valve Disease

Volumn 18, Issue 1, 2009, Pages 52-60

  Sherif, Hisham M F ^a  

^a CHRISTIANA HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANIMAL; AORTA VALVE; CALCINOSIS; HUMAN; INFLAMMATION; MITRAL VALVE; PATHOLOGY; PATHOPHYSIOLOGY; REVIEW; VALVULAR HEART DISEASE;

ANIMALS; AORTIC VALVE; CALCINOSIS; HEART VALVE DISEASES; HUMANS; INFLAMMATION; MITRAL VALVE;

EID: 65349094607     PISSN: 09668519     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (120)

1. McMillan JB, Lev M. The aging heart II. The valves. J Gerontol 1964;19:1-14
2. Beregovich J, Reicher-Reiss H. Calcification of the tricuspid valve: A case report. Vase Surg 1973;4:200-205
3. Boudoulas H, Gravanis MB. Valvular heart disease. In: Gravanis MB (ed). Cardiovascular Disorders. Mosby 1993:64-117
4. Boudoulas H, Vavuranakis, Wooley CF. Valvular heart disease: The influence of changing etiology on nosology. J Heart Valve Dis 1994;3:516-526 (Pubitemid 24305459)
5. Coombs CF. Rheumatic heart disease. William Wood and Co., New York, 1924
6. Rajamannan NM, Nealis TB, Subramaniam M, et al. Calcific rheumatic valve neoangiogenesis is associated with vascular endothelial growth factor expression and osteoblast-like bone formation Circulation 2005;111:3296-3301 (Pubitemid 40875003)
7. Parillo SJ. Rheumatic fever. Web article. Available at eMedicine from WebMD. February 2007. Available at: http://www.emedicine.com/emerg/topic509.htm
8. Chin TK. Rheumatic heart disease. Web article. Available at eMedicine from WebMD. May 2006. Available at: http://www.emedicine.com/ped/topic2007.htm
9. Kouvaras G, Manolis A, Cokkinos D. Calcification of the tricuspid annulus: Case report and review of the literature. Jpn Heart J 1987;28:561-566 (Pubitemid 17140492)
10. Malkawi K, Bouchard F, Maurice P. Calcification de l'anneau tricuspidien. Arch Mal Coeur 1981;4:487-492
11. Chopra P, Tandon HD. Pathology of chronic rheumatic heart disease with particular reference to tricuspid valve involvement. Acta Cardiologica 1977;6:423-434 (Pubitemid 8304258)
12. Rose AG. Etiology of valvular heart disease. Curr Opin Cardiol 1996;11:98-113
13. Soler-Soler J, Galve E. Valve disease: Worldwide perspective of valve disease. Heart 2000;83:721-725
14. Lopez JA, Ross RS, Fishbein MC, Seigel RL. Nonbacterial thrombotic endocarditis: A review. Am Heart J 1987;113:773
15. Dare AJ, Veinot JP, Edwards WD, et al. New observations on the etiology of aortic valve disease: A surgical pathologic study of 236 cases from 1990. Hum Pathol 1993;24:1330-1338 (Pubitemid 24033736)
16. Boon A, Cheriex E, Lodder J, Kessels F. Cardiac valve calcification: Characteristics of patients with calcification of the mitral annulus or aortic valve. Heart 1997;78:472-474 (Pubitemid 27515107)
17. Livi U, Abdulla A, Parker R, Olsen EJ, Ross DN. Viability and morphology of aortic and pulmonary homografts. J Thorac Cardiovasc Surg 1987:93:755-760 (Pubitemid 17070714)
18. Smith JD, Ogino H, Hunt D, Laylor RM, Rose M, Yacoub MH. Humoral immune response to human aortic valve homografts. Ann Thorac Surg 1995;60:S127-S130
19. Shaddy RE, Tani LY, Sturtevan JE, Lambert LM, McCough EC. Effects of homograft blood type and anatomic type on stenosis, regurgitation and calcium in homografts in the pulmonary position. Am J Cardiol 1992;70:392-393
20. Zehr KJ, Yagubyan M, Connolly HM, Nelson SM, Schaff HV. Aortic root replacement with a novel decellularized cryopreserved aortic homograft: Postoperative immunoreactivity and early results. J Thorac Cardiovasc Surg 2005;130:1010-1015 (Pubitemid 41427331)
21. Dearani JA, Danielson GK, Puga FJ, et al. Late follow-up of 1095 patients undergoing operations for complex congenital heart disease utilizing pulmonary ventricle to pulmonary artery conduits. Ann Thorac Surg 2003;75:399-411 (Pubitemid 36184480)
22. Alexi-Mekhishvilli V, Photidias J, Niirnberg J-H. Replacement of the aortic valve after the arterial switch operation. Cardiol Young 2003;13:191-193
23. Gates RN, Laks H, Elami A, et al. Damus-Stansel-Kaye procedure: Current indications and results. Ann Thorac Surg 1993;56:111-119 (Pubitemid 23227246)
24. Ward KE, Elkins RC, Overholt ED, et al. Evaluation of cryopreserved homografts in the right ventricular outflow tract after the Ross procedure: Intermediate-term follow-up. J Heart Valve Dis 1997;6:130-133. (Pubitemid 27166172)
25. Oswalt JD, Dewan SJ, Mueller MC, Nelson S. Highlights of a ten-year experience with the Ross procedure. Ann Thorac Surg 2001;71(suppl.):332-335
26. Raanani E, Yau TM, David TE, Dellgreen G, Sonnenberg BD, Omran A. Risk factors for late pulmonary homograft stenosis after the Ross procedure. Ann Thorac Surg 2000;70:1953-1957 (Pubitemid 32015670)
27. Brown JW, Ruzmetov M, Rodefeld MD, Mahomed Y, Turrentine MW. Incidence of and risk factors for pulmonary autograft dilation after Ross aortic valve replacement. Ann Thorac Surg 2007;83:1781-1789 (Pubitemid 46621122)
28. David TE, Omran A, Ivanov J, Armstrong S, Mauro PLD. Dilatation of the pulmonary autograft after the Ross procedure. J Thorac Cardiovasc Surg 2000;71:911-917
29. Simon-Kupilik N, Bialy J, Moidl R, et al. Dilatation of the aortic root after the Ross operation. Eur J Cardiothorac Surg 2002;21:470-473 (Pubitemid 34224803)
30. Carr-White GS, Kilner PJ, Hon JK, et al. Incidence, location, pathology, and significance of pulmonary homograft stenosis after the Ross operation. Circulation 2001;104:116-120
31. Ross DB, Hamilton GR, Wright JR, Lee TDG. Letter to the Editor. Homograft valve failure in children. J Thorac Cardiovasc Surg 1999;117:1044
32. Bando K, Danielson GK, Schaff HV, Mair DD, Julsrud PR, Puga, FJ. Outcomes of pulmonary and aortic homografts for right ventricular outflow tract reconstruction. J Thorac Cardiovasc Surg 1995;109:509-518
33. Yankah AC, Alexi-Mekhishvilli VA, Weng Y, Berger F, Lange PE, Hetzer R. Performance of aortic and pulmonary homografts in the right ventricular outflow tract in children. J Heart Valve Dis 1995;4:392-395
34. Tweddell JS, Pelech AN, Frommelt PC, et al. Factors affecting longevity of homograft valves used in right ventricular outflow tract reconstruction for congenital heart disease. Circulation 2000;102(Suppl. III):III130-III135
35. Schorn K, Yankah AC, Alexi-Mekhishvilli VA, Weng Y, Lange PE, Hetzer R. Risk factors for early degeneration of allografts in pulmonary circulation. Eur J Cardiothorac Surg 1997;11:62-69 (Pubitemid 27076115)
36. Bisse GS, Schwartz DC, Benzing G, et al. Late results of reconstruction of the right ventricular outflow tract with porcine xenografts in children. Ann Thorac Surg 1981;31:437-443 (Pubitemid 11116989)
37. Rocchini AP, Rosenthal A, Keane JF, Castaneda AR, Nadas AS. Hemodynamics after surgical repair with right ventricle to pulmonary artery conduit. Circulation 1976;54:951-956
38. Brown JW, Ruzmetov M, Rodefeld MD, Vijay P, Turrentine MW. Right ventricular outflow tract reconstruction with an allograft conduit in non-Ross patients: Risk factors for allograft dysfunction and failure. Ann Thorac Surg 2005;80:655-63; discussion 663-664
39. Christenson JT, Vala D, Sierra J, Beghetti M; Kalangos A. Blood group incompatibility and accelerated homograft fibrocalcifications. J Thorac Cardiovasc Surg 2004;127:242-250 (Pubitemid 38160489)
40. Shaddy RE, Tani LY, Sturtevan JE, Lambert LM, McCough EC. Effects of homograft blood type and anatomic type on stenosis, regurgitation and calcium in homografts in the pulmonary position. Am J Cardiol 1992;70:392-393
41. Schoen FJ, Levy JL. Calcification of tissue heart valve substitutes: Progress toward understanding and prevention. Ann Thorac Surg 2005;79:1072-1080 (Pubitemid 40288798)
42. Levy RJ, Vyavahare N, Matthew, Ashworth P, Bianco R Schoen FJ. Inhibition of cusp and aortic wall calcification in ethanol-and aluminum-treated bioprosthetic heart valves in sheep: Background, mechanisms and synergism. J Heart Valve Dis 2003;12:209-216 (Pubitemid 36411103)
43. Ohashi KL, Culkar J, Riebman JB, Estes M, Constantz BR, Yoganathan AP. Hemodynamic characterization of calcified stenotic human aortic valves before and after treatment with a novel aortic valve repair system. J Heart Valve Dis 2004;13:582-592; discussion 592
44. Levy RJ, Schoen JT, Nelson AC, Howard SL, Oshry LJ. Biologic determinants of dystrophic calcification and osteocalcin deposition in glutaraldehyde- preserved porcine aortic valve leaflets implanted subcutaneously in rats. Am Pathol 1983;113:143-155 (Pubitemid 13023450)
45. Hoekstra ME, Witvliet M, Knoo CY, et al. Immunogenic human leukocyte antigen class II antigens on human cardiac valves induce specific alloantibodies. Ann Thorac Surg 1998;66:2022-2026 (Pubitemid 29087199)
46. Meuris B, Ozaki S, Herijgers P, et al. Bioprosthetic tissue calcification: Influence of blood contact and arterial pressure. An experimental study in rats and sheep. J Heart Valve Dis 2003;13:392-399. (Pubitemid 36675654)
47. Koutsopoulos S, Kontogeorgeou J, Petroheilos E, Dalas E. Calcification of porcine and human cardiac valves: Testing of various inhibitors for antimineralization. J Mater Sci Mater Med 1998;9:421-424 (Pubitemid 28344801)
48. Shigeuki O, Herijigers P, Flameng W. Influence of blood contact on the calcification of glutaraldehyde-pretreated porcine aortic valves. Ann Thorac Cardiovasc Surg 2003;9:254-255
49. Dignan R, O'Brien M, Hogan P, et al. Aortic valve allograft structural deterioration is associated with a subset of antibodies to human leukocyte antigens. J Heart Valve Dis 2003;12:382-390; discussion 390-391
50. Ross J, Brunwald E. Aortic stenosis. Circulation 1968;381(suppl.):61-67
51. Freeman RV, Otto CM. The spectrum of calcific aortic valve disease: Pathogenesis, disease progression and treatment strategies. Circulation 2005;111:3316-3326 (Pubitemid 40875006)
52. Mohler E, III. Vascular calcification: good, bad or ugly? Vasc Med 2002;7:161-162 (Pubitemid 36104315)
53. O'Brien K. Pathogenesis of calcific aortic valve disease. A disease process comes of age (and a good deal more). Arterioscler Thromb Vase Biol 2006;26:1721-1728 (Pubitemid 44305324)
54. Stewart BF, Siscovick D, Lind BK, et al. Clinical factors associated with calcific aortic valve disease. Cardiovascular Health Study. J Am Coll Cardiol 1997;29:630-634 (Pubitemid 27116107)
55. Mohler ER, Sheridan MJ, Nichols R, Harvey WP, Waller BF. Development and progression of aortic valve stenosis: Atherosclerotic risk factors - a causal relationship? A clinical morphologic study Clin Cardiol 1991;14:995-999
56. Mohler ER, III, Gannon F, Reynolds C, et al. Bone formation and inflammation in cardiac valves. Circulation 2001;103:1522-1528 (Pubitemid 32226259)
57. Arumugam SB, Sankar NM, Cherian KM. Osseous metaplasia with functioning marrow in a calcific aortic valve. J Cardiovasc Surg 1995;10:610-611
58. Rajamannan NM, Subramaniam M, Rickard D, et al. Human aortic valve calcification is associated with an osteoblast phenotype. Circulation 2003;107:2181-2184 (Pubitemid 36547209)
59. Rajamannan NM. Aortic stenosis as an active inflammatory process: The role of medical therapy. Presentation at the American Association for Thoracic Surgery 2005 Valvular Heart Disease Postgraduate Course, Chicago, IL
60. Mohler ER, Adam LP, McLelland P, et al. Detection of osteopontin in calcific human aortic valves. Arterioscler Thromb Vasc Biol 1997;17:547-552 (Pubitemid 27133146)
61. O'Brien KD, Kuusisto J, Reichenbach DD, et al. Osteopontin is expressed in human aortic valvular lesions. Circulation 1995;92:2153-2168
62. Boström K, Watson K, Horn S, et al. Bone morphology protein expression in human atherosclerotic lesions. J Clin Invest 1993;91:1800-1809 (Pubitemid 23127387)
63. Kaden JJ, Bickelhaupt S, Grobholz R, et al. Expression of bone sialoprotein and bone morphogenetic protein-c in calcific aortic stenosis. J Heart Valve Dis 2004;13:560-566
64. Vattikuti R, Towler D. Osteogenic regulation of vascular calcification: An early perspective. Am J Physiol Endocrinol Metab 2004;286:E686-E692
65. Mohler ER, Gannon F, Reynolds C, Zimmerman R, Keane MG, Kaplan FS. Bone formation and inflammation in cardiac valves. Circulation 2001;102:1522-1528 (Pubitemid 32226259)
66. Dhore CR, Cleutjens JPM, Lutgens E, et al. Differential expression of bone matrix regulatory proteins in human atherosclerotic plaques. Arterioscler Thromb Vasc Biol 2001;21:1998-2003 (Pubitemid 34219753)
67. Forrester J, Libby P. The inflammation hypothesis and its potential relevance to statin therapy. Am J Coll Cardiol 2007;99:732-738
68. Watson KE, Demer LL. The atherosclerosis-calcification link? Curr Opin Lipid 1996;7:101-104 (Pubitemid 126426341)
69. Libby P. Inflammation in atherosclerosis. Nature 2002;19:868-874 (Pubitemid 36019640)
70. Libby P, Ridker PM, Maseri A. Inflammation and atherosclerosis. Circulation 2002;105:1135-1143 (Pubitemid 34212626)
71. Libby P. Inflammation and cardiovascular disease mechanisms. Am J Clin Nutr 2006;83(suppl.):456S-460S
72. Hansson GK, Libby P. The immune response in atherosclerosis: A double-edged sword. Nat Rev Immunol 2006;6:508-519 (Pubitemid 43980523)
73. Steffens S, Mach F. Inflammation and atherosclerosis. Herz 2004;29:741-748 (Pubitemid 40125708)
74. Croce K, Libby P. Intertwining of thrombosis and inflammation in atherosclerosis. Curr Opin Hematol 2007;114:55-61 (Pubitemid 44885613)
75. Luster AD. Chemokines - chemotactic cytokines that mediate inflammation. N Engl J Med 1998;338:436-445 (Pubitemid 28135672)
76. Mach F, Sauty A, Larossi AS, et al. Differential expression of three T-lymphocyte activating CXC chemokines by human atheroma-associated cells. Clin Invest 1999;8:1041-1050 (Pubitemid 29536314)
77. Mach F. The role of chemokines in atherosclerosis. Curr Atherosc Rep 2001;3:243-251
78. Cines DB, Pollack ES, Buck CA, et al. Endothelial cells in physiology and in the pathophysiology of vascular disorders. Blood 1998;91:3527-3561 (Pubitemid 28225719)
79. Stacker R, Keaney JF, Jr. Role of oxidative modification in atherosclerosis. Physiol Rev 2004;84:1381-1478
80. Napoli C, Ignarro LJ. Nitric oxide and atherosclerosis. Nitric Oxide 2001;2:88-97 (Pubitemid 34142732)
81. Mach F. Pro-and Anti-inflammatory pathways in atherosclerosis. Oral presentation at 'Inflammation in Atherosclerosis: Thirty years of exploration in basic and clinical science' conference. Boston, MA, 2007
82. Shimizu K, Mitchell RN, Libby P. Inflammation and cellular immune response in abdominal aortic aneurysm. Arterioscler Thromb Vasc Biol 2006;26:987-994 (Pubitemid 43732102)
83. Agmon Y, O'Fallon WM, Smith TF, Wiebers DO, Meissner I. Inflammation, infection and aortic valve sclerosis: Insights from the Olmstead County (Minnesota) population. Atherosclerosis 2004;174:337-342 (Pubitemid 38597091)
84. Agmon Y, Khanderia BK, Meissner I, et al. Aortic valve sclerosis and aortic atherosclerosis: Different manifestations of the same disease? Insights from a population-based study. J Am Coll Cardiol 2001;40:1723-1730
85. Wierzbicki A, Sherry C. Aortic stenosis: An atherosclerotic disease? J Heart Valve Dis 1999;8:416-423 (Pubitemid 29396398)
86. Selzer A. Changing aspects of the natural history of valvular aortic stenosis. N Engl J Med 1987;317:91-98 (Pubitemid 17093738)
87. Rajamannan NM, Gersh B, Bonow RO. Calcific aortic stenosis: From bench to the bedside - emerging clinical and cellular concepts. Heart 2003;89:801-805 (Pubitemid 36760652)
88. Mohler ER. Are atherosclerotic processes involved in aortic valve calcification? Lancet 2000;356:524-525
89. Boon A, Cheriex E, Lodder J, Kessels F. Cardiac valve calcification: Characteristics of patients with calcification of the mitral annulus or aortic valve. Heart 1997;78:472-474 (Pubitemid 27515107)
90. Wang AY-M, Ho SS-Y, Wang M, et al. Cardiac valvular calcification as a marker of atherosclerosis and arterial calcification in end-stage renal disease. Arch Intern Med 2005;165:327-332 (Pubitemid 40216288)
91. Mazzone A, Epistolato MC, De Catrina E, et al. Neoangiogenesis, T-lymphocyte infiltration and heat shock protein-60 are biological hallmarks of an immunomediated inflammatory process in end-stage calcific aortic stenosis. J Am Coll Cardiol 2004;43:1670-1676 (Pubitemid 38561351)
92. Kaden JJ, Dempfle C-E, Grobholz R, et al. Inflammatory regulation of extracellular matrix remodeling in calcific aortic valve stenosis. Cardiovasc Pathol 2005;14:80-87 (Pubitemid 40381303)
93. Mehar VC, Ramgolam VS, Bender JR. Cytokines and cardiovascular disease. J Leukoc Biol 2005;78:805-818 (Pubitemid 41384397)
94. Demer LL. Cholesterol in vascular and valvular calcification. Circulation 2001;104:1881-1883 (Pubitemid 32983227)
95. Demer LL. Vascular calcification and osteoporosis: Inflammatory responses to oxidized lipids. Int J Epidemiol 2002;31:737-741 (Pubitemid 34947236)
96. Deutcher S, Rockette HE, Krishnaswami V. Diabetes and hypercholesterolemia among patient with calcific stenosis. J Chron Dis 1994;37:407-410
97. Watson KE, Bostrom K, Ravindranath R, et al. TGF-beta 1 and 25-hydroxycholesterol stimulate osteoblast-like vascular cell to calcify. J Clin Invest 1994;93:2106-2013
98. O'Brien KD, Reichenbach DD, Marcovina SM, et al. Apolipoprotein B, (a) and E accumulate in the morphologically early lesions of 'degenerative' valvular aortic stenosis. Arterioscler Thromb Vasc Biol 1996;16:523-532 (Pubitemid 26107723)
99. Olsson M, Thyberg J, Nilsson J. Presence of oxidized low density lipoprotein in nonrheumatic stenotic aortic valves. Arterioscler Thromb Vasc Biol 1999;19:1218-1222 (Pubitemid 29227640)
100. lOO. Galante A, Pietroiusti A, Vellini M, et al. C-Reactive protein is increased in patients with degenerative aortic valvular stenosis. J Am Coll Cardiol 2001;38:1978-1082
101. Novaro GM, Aronow HD, Mayer-Sabik E, Griffin BP. Plasma homocysteine and calcific aortic valve disease. Heart 2004;90:802-803 (Pubitemid 38813646)
102. Jian B, Narula N, Li QY, Mohler ER, III, Levy RJ. Progression of aortic valve stenosis: TGF-beta 1 is present in calcific aortic cusps and promotes aortic valve interstitial cell calcification via apoptosis. Ann Thorac Surg 2003;75:457-465 (Pubitemid 36184488)
103. Clarke-Greuel JN, Connolly JM, Sorichillo E, et al. Transforming growth factor-b1 mechanisms in aortic valve calcification: Increased alkaline phosphatase and related events. Ann Thorac Surg 2007;83:946-953 (Pubitemid 46328821)
104. O'Brien KD, Shavelle DM, Caulfield MT, et al. Association of angiotensin-converting enzyme and low-density lipoprotein in aortic valvular lesions and in human plasma. Circulation 2002;106:2224-2230 (Pubitemid 35222217)
105. Fondard O, Detaint D, Iung B, et al. Extracellular matrix remodeling in human aortic valve disease: The role of matrix metalloproteinases and their inhibitors. Eur Heart J 2005;26:1333-1341 (Pubitemid 41435466)
106. Aikawa E, Nahrendorf M, Sosnovik D, et al. Multimodality molecular imaging identifies proteolytic and osteogenic activities in early aortic valve disease. Circulation 2007;115:377-386 (Pubitemid 46148512)
107. Deguchi J, Aikawa M, Tung C-H, et al. Inflammation in atherosclerosis. Visualizing matrix metalloproteinase action in macrophages in vivo. Circulation 2006;114:55-62 (Pubitemid 44305275)
108. Olsson M, Dalsgaard CJ, Haegerstrand A, Rosenqvist M, Ryden L, Nilsson J. Accumulation of T lymphocytes and expression of interleukin-2 receptors in nonrheumatic stenotic aortic valves. J Am Coll Cardiol 1994;23:1162-1170 (Pubitemid 24117151)
109. Helske S, Syvaranta S, Lindstedt KA, et al. Increased expression of elastolytic cathepsins S, K and V and their inhibitor cystatin C in stenotic aortic valves. Arterioscler Thromb Vase Biol 2006;26:1791-1798 (Pubitemid 44313582)
110. Srivasta SS, Harrity PJ, Maercklein PB, et al. Increased cellular expression of matrix proteins that regulate mineralization is associated with calcification of native human and porcine xenograft bioprosthetic heart valves. J Clin Invest 1997;99:996-1009 (Pubitemid 27123637)
111. Merryman WD, Liao J, Parekh A, et al. Differences in tissue remodeling potential of aortic and pulmonary heart valve interstitial cells. Tissue Eng 2007;13:2281-2289 (Pubitemid 47404443)
112. Suvorova EI, Buffatt PA. Pathological mineralization of cardiac valves: Causes and mechanism. J Long-term Effects Medical Implants 2005;15:355-367 (Pubitemid 41277215)
113. Urist MR. Origins of current ideas about calcification. Clin Orthop Relat Res 1988;44:13-39
114. Boskey AL. Current concepts of the physiology and biochemistry of calcification. Clin Orthop Relat Res 1981; Section III: 225-257 (Pubitemid 11072171)
115. Anderson HC. Calcification process. Path Ann 1980;15:45
116. Anderson HC. Mechanisms of pathologic calcification. Rheum Dis Clin North Am 1988;14:303-319
117. Gerlach U, Holing JH, Themann H. Metabolism and structure of connective tissue during extraosseous calcification. Clin Orthop Relat Res 1970;69:118-134
118. Seifert G. Morphologic and biochemical experimental extraosseous tissue calcification. Clin Orthop Relat Res 1970;69:146-158
119. Finn W. Hyperphosphatemia and cardiovascular disease? What is the effect of phosphate on cardiovascular disease? Ask the Experts. Medscape Nephrology. Available at: http://www.medscape.com/viewarticle/513547
120. Ott S. Bone remodeling. Online Courses, University of Washington, Seattle, WA. Available at: http://courses.washington. edu/bonephys/phys remod.html